CoChat

Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer

Open access
Kim, J. Julie, Kurita, Takeshi, Bulun, Serdar E. · 2013 · Endocrine Reviews

The DOI matches its Crossref record; 335 of the 343 references it cites were found in a registry or an index.

Abstract

Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estrogen, considered to be the mitogenic factor. Emerging evidence supports distinct roles of progesterone and its influence on the pathogenesis of these diseases. Progesterone antagonizes estrogen-driven growth in the endometrium, and insufficient progesterone action strikingly increases the risk of endometrial cancer. In endometriosis, eutopic and ectopic tissues do not respond sufficiently to progesterone and are considered to be progesterone-resistant, which contributes to proliferation and survival. In uterine fibroids, progesterone promotes growth by increasing proliferation, cellular hypertrophy, and deposition of extracellular matrix. In normal mammary tissue and breast cancer, progesterone is pro-proliferative and carcinogenic. A key difference between these tissues that could explain the diverse effects of progesterone is the paracrine interactions of PR-expressing stroma and epithelium. Normal endometrium is a mucosa containing large quantities of distinct stromal cells with abundant PR, which influences epithelial cell proliferation and differentiation and protects against carcinogenic transformation. In contrast, the primary target cells of progesterone in the breast and fibroids are the mammary epithelial cells and the leiomyoma cells, which lack specifically organized stromal components with significant PR expression. This review provides a unifying perspective for the diverse effects of progesterone across human tissues and diseases.

Overview

Integrity signals

Registry

Crossref · 10.1210/er.2012-1043

Cites

335 of 335 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 335 references

Research works printed but not linked: 1

  1. Kim, 1997, Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature, Cancer, 79, 320, 10.1002/(sici)1097-0142(19970115)79:2<320::aid-cncr15>3.0.co;2-2 · DOI · Paper page

Cited by

Metadata

Authors
Kim, J. J., Kurita, T., & Bulun, S. E.
Affiliations
Northwestern University (US)
Corresponding author
Bulun, Serdar E.
Venue
Endocrine Reviews
Published
2013-01-09
Volume
34
Issue
1
Pages
130-162
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2023298070
Cited by
520
References
343
Citations by year
2026: 29 · 2025: 38 · 2024: 49 · 2023: 41 · 2022: 46 · 2021: 44 · 2020: 38 · 2019: 40 · 2018: 28 · 2017: 34 · 2016: 38 · 2015: 35 · 2014: 45 · 2013: 15
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (R01CA155513, R21CA127674, R01CA154358)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD044715, R37-HD36891, P01HD057877, R01HD064402)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords
progesterone, progesterone receptor, endometrial cancer, endometriosis, uterine fibroids, breast cancer, estrogen, progesterone resistance, paracrine signaling, stromal-epithelial interactions, mammary epithelial cells, leiomyoma cells, extracellular matrix deposition, carcinogenesis, uterine pathology
MeSH terms
Animals, Breast Neoplasms, Cell Differentiation, Endometriosis, Estrogens, Female, Humans, Leiomyoma, Pregnancy, Progesterone, Receptors, Progesterone, Endometrial Neoplasms, Stromal Cells, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.